Clinical trial to evaluate the efficacy and safety of PTFE-coated biliary stents

Clinical trial to evaluate the efficacy and safety of PTFE-coated biliary stents for biliary drainage during neoadjuvant chemotherapy for pancreatic cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1062250098

Enrollment

Registered

2026-03-10

Start date

2026-04-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resectable or borderline resectable pancreatic cancer requiring biliary drainage

Interventions

During endoscopic biliary drainage, the stent will be standardized to a PTFE-coated stent group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with resectable or borderline resectable pancreatic cancer who require biliary drainage. 2. Patients who have received a full explanation of the study, have adequately understood the information provided, and are able to voluntarily provide written informed consent. 3. Patients who are 18 years of age or older at the time of providing informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to undergo endoscopic procedures. 2. Patients who will not receive preoperative chemotherapy or surgery. 3. Pregnant women or women who may be pregnant. 4. Patients deemed inappropriate for study participation by the principal investigator or sub-investigators.

Design outcomes

Primary

Measure	Time frame
Incidence of events (stent occlusion, cholecystitis, pancreatitis)	—

Secondary

Measure	Time frame
1. Technical success rate 2. Clinical success rate 3. Adverse event rate	—

Contacts

Public ContactAkihiro Matsumi

Okayama University Hospital

pxbb7o3o@okayama-u.ac.jp+81-86-235-7219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026